Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model : in situ detection of 2-HG and [alpha]-KG
Avtorji:ID Navis, Anna C. (Avtor)
ID Niclou, Simone P. (Avtor)
ID Fack, Fred (Avtor)
ID Stieber, Daniel (Avtor)
ID Lith, Sanne A. M. van (Avtor)
ID Verrijp, Kiek (Avtor)
ID Wright, Alan F. (Avtor)
ID Stauber, Jonathan (Avtor)
ID Tops, Bastiaan (Avtor)
ID Otte-Holler, Irene (Avtor)
ID Wevers, Ron A. (Avtor)
ID Rooij, Arno van (Avtor)
ID Pusch, Stefan (Avtor)
ID Deimling, Andreas von (Avtor)
ID Tigchelaar, Wikky (Avtor)
ID Noorden, Cornelis J. F. van (Avtor)
ID Wesseling, Pieter (Avtor)
ID Leenders, William P. J. (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://doi.org/10.1186/2051-5960-1-18
 
.pdf PDF - Predstavitvena datoteka, prenos (1,76 MB)
MD5: DD7DE412BB3AF3306FA8C35B5B862A13
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo NIB - Nacionalni inštitut za biologijo
Povzetek:Background Point mutations in genes encoding NADP+-dependent isocitrate dehydrogenases (especially IDH1) are common in lower grade diffuse gliomas and secondary glioblastomas and occur early during tumor development. The contribution of these mutations to gliomagenesis is not completely understood and research is hampered by the lack of relevant tumor models. We previously described the development of the patient-derived high-grade oligodendroglioma xenograft model E478 that carries the commonly occurring IDH1-R132H mutation. We here report on the analyses of E478 xenografts at the genetic, histologic and metabolic level. Results LC-MS and in situ mass spectrometric imaging by LESA-nano ESI-FTICR revealed high levels of the proposed oncometabolite D-2-hydroxyglutarate (D-2HG), the product of enzymatic conversion of α-ketoglutarate (α-KG) by IDH1-R132H, in the tumor but not in surrounding brain parenchyma. α-KG levels and total NADP+-dependent IDH activity were similar in IDH1-mutant and -wildtype xenografts, demonstrating that IDH1-mutated cancer cells maintain α-KG levels. Interestingly, IDH1-mutant tumor cells in vivo present with high densities of mitochondria and increased levels of mitochondrial activity as compared to IDH1-wildtype xenografts. It is not yet clear whether this altered mitochondrial activity is a driver or a consequence of tumorigenesis. Conclusions The oligodendroglioma model presented here is a valuable model for further functional elucidation of the effects of IDH1 mutations on tumor metabolism and may aid in the rational development of novel therapeutic strategies for the large subgroup of gliomas carrying IDH1 mutations.
Ključne besede:gliomaI, IDH mutations, xenograft, D-2-hydroxyglutarate, [alpha]-ketoglutarate, mitochondria: LESA-nano ESI-FTIC
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:29.05.2013
Leto izida:2013
Št. strani:str. 1-12
Številčenje:Vol. 1
PID:20.500.12556/DiRROS-20026 Novo okno
UDK:577.2
ISSN pri članku:2051-5960
DOI:10.1186/2051-5960-1-18 Novo okno
COBISS.SI-ID:4651599 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 19. 3. 2018;
Datum objave v DiRROS:02.08.2024
Število ogledov:6
Število prenosov:5
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Acta neuropathologica communications
Skrajšan naslov:Acta Neuropathol. Commun.
Založnik:BioMed Central
ISSN:2051-5960
COBISS.SI-ID:522939929 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Številka projekta:2010(1)- 01
Naslov:the Hersenstichting

Financer:Drugi - Drug financer ali več financerjev
Program financ.:FNR in Luxembourg
Številka projekta:C10/BM/784322
Naslov:ESCAPE
Akronim:CORE

Financer:Drugi - Drug financer ali več financerjev
Akronim:RUNMC

Licence

Licenca:CC BY 2.0, Creative Commons Priznanje avtorstva 2.0 Generična
Povezava:https://creativecommons.org/licenses/by/2.0/deed.sl
Opis:Dovoljuje kopiranje in razširjanje vsebin v kakršnemkoli mediju in obliki. Dovoljuje remixanje, urejanje, predelava in vključevanje vsebine v lastna dela v vse namene, tudi komercialne. Primerno morate navesti avtorja, povezavo do licence in označiti spremembe, če so kakšne nastale. To lahko storite na kakršenkoli razumen način, vendar ne na način, ki bi namigoval na to, da dajalec licence podpira vas ali vašo uporabo dela. Ne smete uporabiti pravnih določil ali tehničnih ukrepov, ki bi pravno omejili ali onemogočilo druge, da bi storili karkoli, kar licenca dovoli.

Nazaj